German Biochemist Questions Efficacy of Alzheimer's Antibody Therapies

A German biochemist, Christian Behl, expresses skepticism regarding the effectiveness of new antibody therapies for Alzheimer's disease, advocating for alternative research approaches and highlighting factors that increase dementia risk.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman5d ago

Behandlung von Demenz: „Antikörper sind nicht der Gamechanger bei Alzheimer“

Im Kampf gegen Alzheimer ruht die Hoffnung auf neuen Antikörper-Therapien. Der Mainzer Biochemiker Christian Behl zweifelt deren Nutzen an. Er fordert neue Forschungsansätze und sagt, was das Risiko für Demenz erhöht.

Read full article →

PERSPECTA

PERSPECTA

German Biochemist Questions Efficacy of Alzheimer's Antibody Therapies

Sources

Behandlung von Demenz: „Antikörper sind nicht der Gamechanger bei Alzheimer“

Related Stories

Oldest Plague Outbreak Discovered in Siberia, Dating Back 5,500 Years

Extreme Training: What Heat Training Does to the Body

Cameroon Develops 2027–2031 National Health Security Action Plan

Greek Authorities and Experts Issue Advice on Purple Jellyfish and Marine Stings

PERSPECTA